Bullous pemphigoid disease causes large blisters to form all over your body and it can take years of treatment for it to go away. Infections are a risk if you have bullous pemphigoid, so you must ...

Sustained disease remission occurred in 20% ... these results show the potential of Dupixent to transform the treatment paradigm for bullous pemphigoid.” ...

and the latest to be reviewed could throw a lifeline to patients with a rare and debilitating autoimmune disease affecting the skin. Bullous pemphigoid (BP), which has no FDA-approved targeted ...

to treat adults with bullous pemphigoid (BP), a chronic and severe skin disease associated with type 2 inflammation. If approved, Dupixent will be the first targeted treatment for BP in the U.S ...

Bullous pemphigoid is a chronic, relapsing skin disease with underlying type 2 ... or placebo every 2 weeks with oral corticosteroid treatment. Findings showed 20% of dupilumab-treated patients ...

Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivo... Menu icon A vertical stack of three evenly ...

Findings showed 20% of patients treated with dupilumab experienced sustained disease remission at week 36 compared with 4% of those who received placebo. Treatment with dupilumab led to ...

Autoimmune blistering disorders are a group of rare yet impactful conditions that cause painful blisters to form on the skin ...

Patients with comorbid autoimmune bullous disease and acquired hemophilia A who were of older age were significantly associated with mortality.

Learn about blisters causes, how to treat them at home, and when to seek medical help. Here are simple tips to prevent and heal blisters quickly and safely ...

“Bullous pemphigoid is a debilitating skin disease with a high mortality rate ... (n=53), along with standard-of-care OCS. During treatment, all patients underwent a protocol-defined OCS ...